Job:ML researcher - Oxford-GSK Institute for Molecular and Computational Medicine (IMCM) in data analysis and integration in neurodegenerative disease
Entering edit mode
4 weeks ago
SH01 • 0

Closing Date: Thu Jun 09 2022 12:00:00 GMT+0100 (British Summer Time) | Grade 8: £42,149 - £50,296 with a discretionary range to £54,943 per annum

We have an exciting opportunity for a Machine Learning Researcher in data analysis and integration in neurodegenerative disease, to join the Oxford-GSK Institute for Molecular and Computational Medicine (IMCM), Wellcome Centre for Human Genetics, Nuffield Department of Medicine.

As a Machine Learning Researcher, you will provide machine learning expertise for IMCM projects to exploit the potential of data analytics, AI/ML and next generation deep phenotyping to enable the detection of disease endophenotypes and identification of patients and biomarkers for progression. Reporting to IMCM Programme Manager, and in collaboration with the AI/ML team in GSK you will lead in developing a plan for analyses of existing and emerging data types using machine learning, such as single-cell RNA sequencing data, proteomic data, ATAC-seq, electronic health records and spatial imaging for each project, applying existing and developing new machine learning tools and methodologies. You will be responsible for developing hypotheses with the Professors John Todd and Tony Wood, directors of the IMCM, and IMCM Joint Project Teams, accessing appropriate datasets for which to test these hypotheses, carrying out robust analyses and drawing inferences from the data. This will involve collaborations with groups of similar disciplines, working together to pursue shared interests. You will have joint responsibility for the ongoing success of the research programme, keeping in mind the IMCM’s approach and mission.

learning integration Machine IMCM neurodegeneration analysis • 411 views

Login before adding your answer.

Traffic: 1014 users visited in the last hour
Help About
Access RSS

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6